Georgetown University

This study tests a combination of three drugs (tiragolumab, atezolizumab, and bevacizumab) in people with advanced non-squamous non-small-cell lung cancer that has already been treated. The goal is to see if this mix can shrink tumors or slow the disease. About 29 adults with spe…

This study tests a combination of three chemotherapy drugs (fluorouracil, leucovorin, and nanoliposomal irinotecan) in people with advanced biliary tract cancer that has worsened after standard treatment. The goal is to see if this new mix can stop the cancer from growing for at …

This study was designed to see if the drug daratumumab could help people with a blood condition called MGUS who also have nerve damage (peripheral neuropathy). Participants would have received weekly injections for two months, then every other week for four more months. However, …

This study tests an experimental drug called MGC018 in people with a type of advanced lung cancer (extensive-stage small-cell lung cancer) that has come back or not responded to prior treatment. The main goal is to see if the drug can shrink tumors in at least 25% of participants…

This study aims to see if a web-based educational program can help relatives of people with BRCA1 or BRCA2 mutations make informed decisions about genetic testing. About 240 men and women who are first- or second-degree relatives of a BRCA mutation carrier will be randomly assign…

This study looks at whether a six-month, home-based walking program can improve blood sugar, cholesterol, and body measurements in people with and without HIV who have metabolic syndrome. About 50 adults will gradually increase their walking as tolerated. The main goal is to see …